These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 12143138)
1. [Increased risk of bone-fragility-related fractures in TSH--suppressive thyroxine treatment]. Lindstedt G; Nyström E Lakartidningen; 2002 Jun; 99(25):2844-5. PubMed ID: 12143138 [TBL] [Abstract][Full Text] [Related]
2. [Treatment of hypothyroidism]. Haug E Tidsskr Nor Laegeforen; 2002 Apr; 122(9):935-7. PubMed ID: 12082840 [TBL] [Abstract][Full Text] [Related]
3. Bone mineral density changes and bone turnover in thyroid carcinoma patients treated with supraphysiologic doses of thyroxine. Karner I; Hrgović Z; Sijanović S; Buković D; Klobucar A; Usadel KH; Fassbender WJ Eur J Med Res; 2005 Nov; 10(11):480-8. PubMed ID: 16354602 [TBL] [Abstract][Full Text] [Related]
4. Effects of evening vs morning thyroxine ingestion on serum thyroid hormone profiles in hypothyroid patients. Bolk N; Visser TJ; Kalsbeek A; van Domburg RT; Berghout A Clin Endocrinol (Oxf); 2007 Jan; 66(1):43-8. PubMed ID: 17201800 [TBL] [Abstract][Full Text] [Related]
5. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism. Siegmund W; Spieker K; Weike AI; Giessmann T; Modess C; Dabers T; Kirsch G; Sänger E; Engel G; Hamm AO; Nauck M; Meng W Clin Endocrinol (Oxf); 2004 Jun; 60(6):750-7. PubMed ID: 15163340 [TBL] [Abstract][Full Text] [Related]
6. High Prevalence of Radiological Vertebral Fractures in Women on Thyroid-Stimulating Hormone-Suppressive Therapy for Thyroid Carcinoma. Mazziotti G; Formenti AM; Frara S; Olivetti R; Banfi G; Memo M; Maroldi R; Giubbini R; Giustina A J Clin Endocrinol Metab; 2018 Mar; 103(3):956-964. PubMed ID: 29121201 [TBL] [Abstract][Full Text] [Related]
7. Thyroid replacement therapy, thyroid stimulating hormone concentrations, and long term health outcomes in patients with hypothyroidism: longitudinal study. Thayakaran R; Adderley NJ; Sainsbury C; Torlinska B; Boelaert K; Šumilo D; Price M; Thomas GN; Toulis KA; Nirantharakumar K BMJ; 2019 Sep; 366():l4892. PubMed ID: 31481394 [TBL] [Abstract][Full Text] [Related]
8. Treatment of primary hypothyroidism during pregnancy: is there an increase in thyroxine dose requirement in pregnancy? Chopra IJ; Baber K Metabolism; 2003 Jan; 52(1):122-8. PubMed ID: 12524672 [TBL] [Abstract][Full Text] [Related]
9. Initial treatment dose of L-thyroxine in congenital hypothyroidism. Selva KA; Mandel SH; Rien L; Sesser D; Miyahira R; Skeels M; Nelson JC; Lafranchi SH J Pediatr; 2002 Dec; 141(6):786-92. PubMed ID: 12461494 [TBL] [Abstract][Full Text] [Related]
10. Biochemical markers of bone remodeling correlate negatively with circulating TSH in postmenopausal women. Zofkova I; Hill M Endocr Regul; 2008 Sep; 42(4):121-7. PubMed ID: 18999899 [TBL] [Abstract][Full Text] [Related]
11. [Bioequivalence of L-thyroxine tablets and a liquid L-thyroxine solution in the treatment of hypothyroid patients]. Grussendorf M; Vaupel R; Wegscheider K Med Klin (Munich); 2004 Nov; 99(11):639-44. PubMed ID: 15583873 [TBL] [Abstract][Full Text] [Related]
12. Low normal TSH levels are associated with low bone mineral density in healthy postmenopausal women. Kim DJ; Khang YH; Koh JM; Shong YK; Kim GS Clin Endocrinol (Oxf); 2006 Jan; 64(1):86-90. PubMed ID: 16402934 [TBL] [Abstract][Full Text] [Related]
13. Accelerated bone loss in hypothyroid patients overtreated with L-thyroxine. Stall GM; Harris S; Sokoll LJ; Dawson-Hughes B Ann Intern Med; 1990 Aug; 113(4):265-9. PubMed ID: 2375563 [TBL] [Abstract][Full Text] [Related]
14. [Subclinical hypothyroidism--does it have to be treated?]. Gärtner R MMW Fortschr Med; 2004 Sep; 146(39):37-9. PubMed ID: 15532412 [TBL] [Abstract][Full Text] [Related]
15. [The influence of treatment with substitutive or suppressive doses of thyroxine on biochemical bone turnover markers]. Kosińska A; Syrenicz A; Syrenicz M; Kosiński B; Miazgowski T; Garanty-Bogacka B Ann Acad Med Stetin; 2005; 51(2):97-104. PubMed ID: 16519102 [TBL] [Abstract][Full Text] [Related]
16. Subclinical hypothyroidism is characterized by increased QT interval dispersion among women. Bakiner O; Ertorer ME; Haydardedeoglu FE; Bozkirli E; Tutuncu NB; Demirag NG Med Princ Pract; 2008; 17(5):390-4. PubMed ID: 18685279 [TBL] [Abstract][Full Text] [Related]
17. [Treatment with L-thyroxine for differentiated thyroid carcinoma]. Łacka K Wiad Lek; 2001; 54 Suppl 1():368-72. PubMed ID: 12182051 [TBL] [Abstract][Full Text] [Related]
18. Well-being, health-related quality of life and cardiovascular disease risk profile in women with subclinical thyroid disease - a community-based study. Bell RJ; Rivera-Woll L; Davison SL; Topliss DJ; Donath S; Davis SR Clin Endocrinol (Oxf); 2007 Apr; 66(4):548-56. PubMed ID: 17371474 [TBL] [Abstract][Full Text] [Related]
19. Serum lipid levels in relation to serum thyroid-stimulating hormone and the effect of thyroxine treatment on serum lipid levels in subjects with subclinical hypothyroidism: the Tromsø Study. Iqbal A; Jorde R; Figenschau Y J Intern Med; 2006 Jul; 260(1):53-61. PubMed ID: 16789979 [TBL] [Abstract][Full Text] [Related]
20. Prediction of progression to overt hypothyroidism or hyperthyroidism in female relatives of patients with autoimmune thyroid disease using the Thyroid Events Amsterdam (THEA) score. Strieder TG; Tijssen JG; Wenzel BE; Endert E; Wiersinga WM Arch Intern Med; 2008 Aug; 168(15):1657-63. PubMed ID: 18695079 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]